IPSA to Release 'Pimple Clear e', a Medicated Serum to Proactively Prevent Recurring Acne, on June 4

Product Overview

IPSA announced the launch of its new product, 'Pimple Clear e' (quasi-drug), set for release on June 4, 2026. The serum addresses the 'acne cycle' often seen in individuals sensitive to stress and lifestyle disruptions.

Designed for the younger generation struggling with recurring acne, the product provides multi-faceted care to the skin environment prone to breakouts. It features the new moisturizing 'STB Complex' and contains two active ingredients: dipotassium glycyrrhizinate and tranexamic acid, to prevent acne and rough skin.

The serum utilizes a clear, refreshing gel texture that adheres firmly to the skin. Because it can be applied over makeup, it is suitable for daily routines as well as on-the-go care throughout the day. It is formulated to be gentle on the skin, and is free of alcohol (ethanol) and parabens.

Key Features

- Proactively prevents the development of future acne - Refreshing and pleasant texture - Non-sticky and applicable over makeup

Technologies Applied

1. Stress/Dryness support: STB Complex (Neem leaf extract, concentrated glycerin) 2. Skin conditioning: CLM Complex (Peony extract, Sophora flavescens extract, concentrated glycerin) 3. Excess sebum absorption: Sebum-absorbing powder

Product Details

- Product Name: IPSA Pimple Clear e (Quasi-drug) - Content: 25g - Price: 4,070 yen (including tax; 3,700 yen excluding tax)